Abstract: The invention relates to stable ginger extract preparations, characterized by having a content of a native ginger extract and of at least one stabilizing auxiliary agent selected from the group of proton-capturing substances, whereby the chemically stabilizing auxiliary agent preferably belongs to the family of polyvinylpyrrolidones and releases the included pungent agents in solution. Stable ginger extract preparations having large amounts of pharmaceutically relevant pungent agents or essential oils are additionally obtained by carefully carrying out method steps, which are relevant to the production, at a temperature of no greater than 45° C. The inventive preparations remain analytically stable over a long period of time of up to 18 months and longer. The invention also relates to solid galenic dosage forms such as capsules, tablets and dragees all of which containing the stable ginger extract preparations.

Abstract: The hard gelatin capsules contain sustained-release plant extracts containing a free-flowing filling consisting of compactates of the plant extracts coated with film agents or of mixtures of the plant extracts with auxiliary agents. They are prepared by subjecting the plant extracts, which are undiluted or mixed with auxiliary agents, to pressing to ribbons, mechanically comminuting and freeing from the oversize and undersize, coating with film-forming agents and filling into hard gelatin capsules.

Abstract: A purified extract from Harpagophytum procumbens and/or Harpagophytum zeyheri DENCE is obtainable by dissolving an aqueous and/or aqueous/alcoholic extract in water saturated with n-butanol, extracting with n-butanol saturated with water, and removing the n-butanol in vacuo. It may be used for the preparation of medicaments for the treatment of Asthma bronchiale, Colitis ulcerosa, Morbus Crohn, diseases of the rheumatic type, and indications in which an increase of the lipoxygenase level occurs either by medicaments, other substances or diseases.